Axium Capital Recommends Voting Against Soken Chemical's Director Nominees

Axium Capital, holding a 16% voting stake in Soken Chemical, announced its intention to vote against the re-election of several directors and statutory auditors. This decision comes after Soken Chemical repeatedly refused Axium's requests for individual meetings with the board members. Axium argues that this refusal violates corporate governance codes regarding constructive shareholder dialogue and raises concerns about the board's independence.